Cspc Zhongqi Pharmaceutical Technology (shijizhuang) Co. Ltd.

Cspc Zhongqi Pharmaceutical Technology (shijazhuang) Co., Ltd.

Rongduan Wang

Ying Peng

Xiaoliang Wang

Dongmin Shen

Jinghua Yang

Liying Yang

Yipu Feng

Zhentao Liu

Xiaolong Feng

Hongwu Zhang

Zhanqi Niu

Jingguo Sun

Zhankun Yang

The inventive subject matter relates to the use of L-butylphthalide in the manufacturing of medicaments for the prevention and treatment of cerebral ischemia-induced disease. Cerebral ischemia of the animals or human induces cerebral infarction, neurological deficit, memory disorder, cerebral edema, cerebral apoplexy, metabolic disorder of energy, changes of cerebral blood flow, and the like. The in vivo experiments show that L-butylphthalide can effectively reduce the above-mentioned adverse symptoms induced by cerebral ischemia.

Methods of using L-butylphthalide for the prevention and treatment of cerebral ischemia disease

The invention discloses the application of l-n-butylphthalide as formula (I) in preparing a medicine for preventing and treating dementia, in special Alzheimer's disease and vascular dementia. 

Application of L-n-butylphthalide in preventing and treating dementia

Growing community of inventors

Province, China

Rongduan Wang